GL1X · GenesisL1 explorer

Research workbench

Discovery of pyrrolidine-based B-secretase inhibitors: lead advancement through conformational design for maintenance of ligand binding efficiency

Analyse Discovery of pyrrolidine-based B-secretase inhibitors: lead advancement through… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3UFL
Type
protein
Length
373 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-secretase 1
EC
3.4.23.46
UniProt
P56817
Ligands
508, SO4
Pockets
1 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 16% helix, 42% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-secretase 1 (EC 3.4.23.46)protein37316% helix, 42% strandP56817

Ligands and binding sites

  • 508 · (1R,4'S)-3,4-dihydro-2H-spiro[naphthalene-1,3'-pyrrolidin]-4'-yl[(2S,4R)-2,4-diphenylpiperidin-1-yl]methanone · ligand · chains A
  • SO4 · Sulfate ion · ion · 4 copies · chains A
  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15990.720.8061508, GOL

Modifications

Observed in the structure: 3 disulfide (disulfide).

Compared structures

  • 3UFL · Discovery of Pyrrolidine-based b-Secretase Inhibitors: Lead Advancement through… · the same entry in another collection · chain A against A, TM-score 1.00
  • P56817 · AlphaFold monomer V2.0 prediction for beta-secretase 1 (P56817) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.